APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inosine Pranobex

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Selected research

Market Structure

Global Inosine Pranobex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003410326 December 2025198 pages

Choose your research edition.

Industry ResearchInosine Pranobex Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Inosine Pranobex Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Inosine Pranobex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inosine Pranobex Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inosine Pranobex Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.

Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.

Read the full market overview

In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.

This report provides an overview of the global Inosine Pranobex market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inosine Pranobex and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inosine Pranobex sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inosine Pranobex market size, projected growth trends, production technologies, key applications, and end-use industries.

Inosine Pranobex Segment by Company

Newport Pharmaceuticals

Gedeon Richter

Mochida

Sanofi

Andrómaco

Yung Shin

Alfasigma S.p.A.

Polfarmex

Sanfer

Meprofarm

Novell Pharmaceutical

Aflofarm

Inosine Pranobex Segment by Type

Tablet

Syrup

Inosine Pranobex Segment by Application

Immunomodulation

Antiviral

Other

Inosine Pranobex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inosine Pranobex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inosine Pranobex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inosine Pranobex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inosine Pranobex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inosine Pranobex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inosine Pranobex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inosine Pranobex Industry Trends Table 2. Inosine Pranobex Industry Drivers Table 3. Inosine Pranobex Industry Opportunities and Challenges Table 4. Inosine Pranobex Industry Restraints Table 5. Global Inosine Pranobex Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inosine Pranobex Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inosine Pranobex Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inosine Pranobex Sales Market Share by Manufacturers Table 9. Global Inosine Pranobex Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Inosine Pranobex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inosine Pranobex Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inosine Pranobex Manufacturers, Product Type & Application Table 13. Global Inosine Pranobex Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inosine Pranobex by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Syrup Table 18. Global Inosine Pranobex Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Inosine Pranobex Sales by Type (2021-2026) & (K Units) Table 20. Global Inosine Pranobex Sales by Type (2027-2032) & (K Units) Table 21. Global Inosine Pranobex Sales Market Share by Type (2021-2026) Table 22. Global Inosine Pranobex Sales Market Share by Type (2027-2032) Table 23. Global Inosine Pranobex Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Inosine Pranobex Revenue by Type (2021-2026) & (K Units) Table 25. Global Inosine Pranobex Revenue by Type (2027-2032) & (K Units) Table 26. Global Inosine Pranobex Revenue Market Share by Type (2021-2026) Table 27. Global Inosine Pranobex Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Immunomodulation Table 29. Major Manufacturers of Antiviral Table 30. Major Manufacturers of Other Table 31. Global Inosine Pranobex Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Inosine Pranobex Sales by Application (2021-2026) & (K Units) Table 33. Global Inosine Pranobex Sales by Application (2027-2032) & (K Units) Table 34. Global Inosine Pranobex Sales Market Share by Application (2021-2026) Table 35. Global Inosine Pranobex Sales Market Share by Application (2027-2032) Table 36. Global Inosine Pranobex Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Inosine Pranobex Revenue by Application (2021-2026) & (K Units) Table 38. Global Inosine Pranobex Revenue by Application (2027-2032) & (K Units) Table 39. Global Inosine Pranobex Revenue Market Share by Application (2021-2026) Table 40. Global Inosine Pranobex Revenue Market Share by Application (2027-2032) Table 41. Global Inosine Pranobex Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Inosine Pranobex Sales by Region (2021-2026) & (K Units) Table 43. Global Inosine Pranobex Sales Market Share by Region (2021-2026) Table 44. Global Inosine Pranobex Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Inosine Pranobex Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 48. North America Inosine Pranobex Sales by Country (2027-2032) & (K Units) Table 49. Europe Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 51. Europe Inosine Pranobex Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Inosine Pranobex Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Inosine Pranobex Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Inosine Pranobex Sales by Country (2027-2032) & (K Units) Table 58. Global Inosine Pranobex Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Inosine Pranobex Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Inosine Pranobex Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Inosine Pranobex Revenue Market Share by Region (2021-2026) Table 62. Global Inosine Pranobex Revenue Market Share by Region (2027-2032) Table 63. Newport Pharmaceuticals Company Information Table 64. Newport Pharmaceuticals Business Overview Table 65. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Newport Pharmaceuticals Inosine Pranobex Product Portfolio Table 67. Newport Pharmaceuticals Recent Development Table 68. Gedeon Richter Company Information Table 69. Gedeon Richter Business Overview Table 70. Gedeon Richter Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Gedeon Richter Inosine Pranobex Product Portfolio Table 72. Gedeon Richter Recent Development Table 73. Mochida Company Information Table 74. Mochida Business Overview Table 75. Mochida Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mochida Inosine Pranobex Product Portfolio Table 77. Mochida Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sanofi Inosine Pranobex Product Portfolio Table 82. Sanofi Recent Development Table 83. Andrómaco Company Information Table 84. Andrómaco Business Overview Table 85. Andrómaco Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Andrómaco Inosine Pranobex Product Portfolio Table 87. Andrómaco Recent Development Table 88. Yung Shin Company Information Table 89. Yung Shin Business Overview Table 90. Yung Shin Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Yung Shin Inosine Pranobex Product Portfolio Table 92. Yung Shin Recent Development Table 93. Alfasigma S.p.A. Company Information Table 94. Alfasigma S.p.A. Business Overview Table 95. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Alfasigma S.p.A. Inosine Pranobex Product Portfolio Table 97. Alfasigma S.p.A. Recent Development Table 98. Polfarmex Company Information Table 99. Polfarmex Business Overview Table 100. Polfarmex Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Polfarmex Inosine Pranobex Product Portfolio Table 102. Polfarmex Recent Development Table 103. Sanfer Company Information Table 104. Sanfer Business Overview Table 105. Sanfer Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sanfer Inosine Pranobex Product Portfolio Table 107. Sanfer Recent Development Table 108. Meprofarm Company Information Table 109. Meprofarm Business Overview Table 110. Meprofarm Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Meprofarm Inosine Pranobex Product Portfolio Table 112. Meprofarm Recent Development Table 113. Novell Pharmaceutical Company Information Table 114. Novell Pharmaceutical Business Overview Table 115. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Novell Pharmaceutical Inosine Pranobex Product Portfolio Table 117. Novell Pharmaceutical Recent Development Table 118. Aflofarm Company Information Table 119. Aflofarm Business Overview Table 120. Aflofarm Inosine Pranobex Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Aflofarm Inosine Pranobex Product Portfolio Table 122. Aflofarm Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Inosine Pranobex Distributors List Table 126. Inosine Pranobex Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Inosine Pranobex Product Image Figure 2. Global Inosine Pranobex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inosine Pranobex Market Size (2021-2032) & (US$ Million) Figure 4. Global Inosine Pranobex Sales (2021-2032) & (K Units) Figure 5. Global Inosine Pranobex Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inosine Pranobex Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Syrup Image Figure 10. Global Inosine Pranobex Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Inosine Pranobex Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Inosine Pranobex Sales Market Share by Type (2021-2032) Figure 13. Global Inosine Pranobex Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Inosine Pranobex Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Inosine Pranobex Revenue Market Share by Type (2021-2032) Figure 16. Immunomodulation Image Figure 17. Antiviral Image Figure 18. Other Image Figure 19. Global Inosine Pranobex Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Inosine Pranobex Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Inosine Pranobex Sales Market Share by Application (2021-2032) Figure 22. Global Inosine Pranobex Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Inosine Pranobex Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Inosine Pranobex Revenue Market Share by Application (2021-2032) Figure 25. North America Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Inosine Pranobex Sales Market Share by Country (2021-2032) Figure 27. U.S. Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Inosine Pranobex Sales Market Share by Country (2021-2032) Figure 32. Germany Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Inosine Pranobex Sales Market Share by Country (2021-2032) Figure 39. China Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Inosine Pranobex Sales Market Share by Country (2021-2032) Figure 47. Brazil Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Inosine Pranobex Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Inosine Pranobex Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Inosine Pranobex Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Inosine Pranobex Revenue (2021-2032) & (US$ Million) Figure 58. North America Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Inosine Pranobex Revenue (2021-2032) & (US$ Million) Figure 60. Europe Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Inosine Pranobex Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Inosine Pranobex Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Inosine Pranobex Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Inosine Pranobex Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Syrup
Applications
  • Immunomodulation
  • Antiviral
  • Other
Companies covered
  • Newport Pharmaceuticals
  • Gedeon Richter
  • Mochida
  • Sanofi
  • Andrómaco
  • Yung Shin
  • Alfasigma S.p.A.
  • Polfarmex
  • Sanfer
  • Meprofarm
  • Novell Pharmaceutical
  • Aflofarm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inosine Pranobex Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inosine Pranobex Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inosine Pranobex Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inosine Pranobex Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inosine Pranobex Market Dynamics
  1. 2.1 Inosine Pranobex Industry Trends
  2. 2.2 Inosine Pranobex Industry Drivers
  3. 2.3 Inosine Pranobex Industry Opportunities and Challenges
  4. 2.4 Inosine Pranobex Industry Restraints
3 Inosine Pranobex Market by Manufacturers
  1. 3.1 Global Inosine Pranobex Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inosine Pranobex Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inosine Pranobex Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inosine Pranobex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inosine Pranobex Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inosine Pranobex Manufacturers, Product Type & Application
  7. 3.7 Global Inosine Pranobex Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inosine Pranobex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inosine Pranobex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inosine Pranobex Tier 1, Tier 2, and Tier 3
4 Inosine Pranobex Market by Type
  1. 4.1 Inosine Pranobex Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Syrup
  4. 4.2 Global Inosine Pranobex Sales by Type
  5. 4.2.1 Global Inosine Pranobex Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inosine Pranobex Sales by Type (2021-2032)
  7. 4.2.3 Global Inosine Pranobex Sales Market Share by Type (2021-2032)
  8. 4.3 Global Inosine Pranobex Revenue by Type
  9. 4.3.1 Global Inosine Pranobex Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Inosine Pranobex Revenue by Type (2021-2032)
  11. 4.3.3 Global Inosine Pranobex Revenue Market Share by Type (2021-2032)
5 Inosine Pranobex Market by Application
  1. 5.1 Inosine Pranobex Application Introduction
  2. 5.1.1 Immunomodulation
  3. 5.1.2 Antiviral
  4. 5.1.3 Other
  5. 5.2 Global Inosine Pranobex Sales by Application
  6. 5.2.1 Global Inosine Pranobex Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inosine Pranobex Sales by Application (2021-2032)
  8. 5.2.3 Global Inosine Pranobex Sales Market Share by Application (2021-2032)
  9. 5.3 Global Inosine Pranobex Revenue by Application
  10. 5.3.1 Global Inosine Pranobex Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inosine Pranobex Revenue by Application (2021-2032)
  12. 5.3.3 Global Inosine Pranobex Revenue Market Share by Application (2021-2032)
6 Global Inosine Pranobex Sales by Region
  1. 6.1 Global Inosine Pranobex Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inosine Pranobex Sales by Region (2021-2032)
  3. 6.2.1 Global Inosine Pranobex Sales by Region (2021-2026)
  4. 6.2.2 Global Inosine Pranobex Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inosine Pranobex Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inosine Pranobex Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inosine Pranobex Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inosine Pranobex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inosine Pranobex Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inosine Pranobex Revenue by Region
  1. 7.1 Global Inosine Pranobex Revenue by Region
  2. 7.1.1 Global Inosine Pranobex Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inosine Pranobex Revenue by Region (2021-2026)
  4. 7.1.3 Global Inosine Pranobex Revenue by Region (2027-2032)
  5. 7.1.4 Global Inosine Pranobex Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inosine Pranobex Revenue (2021-2032)
  8. 7.2.2 North America Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inosine Pranobex Revenue (2021-2032)
  11. 7.3.2 Europe Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inosine Pranobex Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inosine Pranobex Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inosine Pranobex Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Newport Pharmaceuticals
  2. 8.1.1 Newport Pharmaceuticals Company Information
  3. 8.1.2 Newport Pharmaceuticals Business Overview
  4. 8.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Newport Pharmaceuticals Inosine Pranobex Product Portfolio
  6. 8.1.5 Newport Pharmaceuticals Recent Developments
  7. 8.2 Gedeon Richter
  8. 8.2.1 Gedeon Richter Company Information
  9. 8.2.2 Gedeon Richter Business Overview
  10. 8.2.3 Gedeon Richter Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Gedeon Richter Inosine Pranobex Product Portfolio
  12. 8.2.5 Gedeon Richter Recent Developments
  13. 8.3 Mochida
  14. 8.3.1 Mochida Company Information
  15. 8.3.2 Mochida Business Overview
  16. 8.3.3 Mochida Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mochida Inosine Pranobex Product Portfolio
  18. 8.3.5 Mochida Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Inosine Pranobex Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Andrómaco
  26. 8.5.1 Andrómaco Company Information
  27. 8.5.2 Andrómaco Business Overview
  28. 8.5.3 Andrómaco Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Andrómaco Inosine Pranobex Product Portfolio
  30. 8.5.5 Andrómaco Recent Developments
  31. 8.6 Yung Shin
  32. 8.6.1 Yung Shin Company Information
  33. 8.6.2 Yung Shin Business Overview
  34. 8.6.3 Yung Shin Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Yung Shin Inosine Pranobex Product Portfolio
  36. 8.6.5 Yung Shin Recent Developments
  37. 8.7 Alfasigma S.p.A.
  38. 8.7.1 Alfasigma S.p.A. Company Information
  39. 8.7.2 Alfasigma S.p.A. Business Overview
  40. 8.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alfasigma S.p.A. Inosine Pranobex Product Portfolio
  42. 8.7.5 Alfasigma S.p.A. Recent Developments
  43. 8.8 Polfarmex
  44. 8.8.1 Polfarmex Company Information
  45. 8.8.2 Polfarmex Business Overview
  46. 8.8.3 Polfarmex Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Polfarmex Inosine Pranobex Product Portfolio
  48. 8.8.5 Polfarmex Recent Developments
  49. 8.9 Sanfer
  50. 8.9.1 Sanfer Company Information
  51. 8.9.2 Sanfer Business Overview
  52. 8.9.3 Sanfer Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanfer Inosine Pranobex Product Portfolio
  54. 8.9.5 Sanfer Recent Developments
  55. 8.10 Meprofarm
  56. 8.10.1 Meprofarm Company Information
  57. 8.10.2 Meprofarm Business Overview
  58. 8.10.3 Meprofarm Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Meprofarm Inosine Pranobex Product Portfolio
  60. 8.10.5 Meprofarm Recent Developments
  61. 8.11 Novell Pharmaceutical
  62. 8.11.1 Novell Pharmaceutical Company Information
  63. 8.11.2 Novell Pharmaceutical Business Overview
  64. 8.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novell Pharmaceutical Inosine Pranobex Product Portfolio
  66. 8.11.5 Novell Pharmaceutical Recent Developments
  67. 8.12 Aflofarm
  68. 8.12.1 Aflofarm Company Information
  69. 8.12.2 Aflofarm Business Overview
  70. 8.12.3 Aflofarm Inosine Pranobex Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aflofarm Inosine Pranobex Product Portfolio
  72. 8.12.5 Aflofarm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inosine Pranobex Value Chain Analysis
  2. 9.1.1 Inosine Pranobex Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inosine Pranobex Production Mode & Process
  6. 9.2 Inosine Pranobex Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inosine Pranobex Distributors
  9. 9.2.3 Inosine Pranobex Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst